[go: up one dir, main page]

NO952261D0 - Antacidium Compounds and Methods of Preparation thereof - Google Patents

Antacidium Compounds and Methods of Preparation thereof

Info

Publication number
NO952261D0
NO952261D0 NO952261A NO952261A NO952261D0 NO 952261 D0 NO952261 D0 NO 952261D0 NO 952261 A NO952261 A NO 952261A NO 952261 A NO952261 A NO 952261A NO 952261 D0 NO952261 D0 NO 952261D0
Authority
NO
Norway
Prior art keywords
antacidium
compounds
preparation
methods
antacidium compounds
Prior art date
Application number
NO952261A
Other languages
Norwegian (no)
Other versions
NO952261L (en
Inventor
Gary G Liversidge
Gregory L Mcintire
Original Assignee
Eastman Kodak Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastman Kodak Co filed Critical Eastman Kodak Co
Publication of NO952261L publication Critical patent/NO952261L/en
Publication of NO952261D0 publication Critical patent/NO952261D0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08Oxides; Hydroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO952261A 1992-12-11 1995-06-08 Antacidium Compounds and Methods of Preparation thereof NO952261D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98929692A 1992-12-11 1992-12-11
PCT/US1993/011720 WO1994013304A2 (en) 1992-12-11 1993-12-03 Antacid composition and method of production

Publications (2)

Publication Number Publication Date
NO952261L NO952261L (en) 1995-06-08
NO952261D0 true NO952261D0 (en) 1995-06-08

Family

ID=25534976

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952261A NO952261D0 (en) 1992-12-11 1995-06-08 Antacidium Compounds and Methods of Preparation thereof

Country Status (10)

Country Link
EP (1) EP0673253A1 (en)
JP (1) JPH08504442A (en)
KR (1) KR950703982A (en)
AU (1) AU6390894A (en)
CA (1) CA2150383A1 (en)
CZ (1) CZ148695A3 (en)
FI (1) FI952859A (en)
NO (1) NO952261D0 (en)
SK (1) SK76595A3 (en)
WO (1) WO1994013304A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3618348B2 (en) * 1993-08-24 2005-02-09 カッパ ファーマシューティカルズ リミテッド Reduced absorption of fatty acids
CA2158977A1 (en) 1994-05-09 1995-11-10 James G. Respess Retroviral vectors having a reduced recombination rate
US5874112A (en) * 1997-03-31 1999-02-23 Mcneil Ppc-Inc. Translucent antacid suspension
AU2002951438A0 (en) * 2002-09-17 2002-10-03 Nauveau Technology Investments Ltd Methods and compositions for treatment of excess stomach acid in mammals
RU2013148719A (en) * 2013-10-31 2015-05-10 Геннадий Гильфанович Галимов COMPOSITION BASED ON MAGNESIUM CHLORIDE HYDROXOALUMINATE, CONTAINING MAGNESIUM HYDROXIDE, AS A THERAPEUTIC DRUG
WO2016104367A1 (en) * 2014-12-22 2016-06-30 株式会社Lttバイオファーマ Functional dyspepsia therapeutic drug

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3843778A (en) * 1970-04-28 1974-10-22 Rorer Inc William H Antacids
US4271142A (en) * 1979-06-18 1981-06-02 Life Savers, Inc. Portable liquid antacids
FR2512344A1 (en) * 1981-09-08 1983-03-11 Af Aplicaciones Far Lab Stable antacid suspension of aluminium and/or magnesium hydroxide(s) - prepd. by mixing powdered prod. with water, fragmenting and dispersing to give particle size of 5-10 microns

Also Published As

Publication number Publication date
JPH08504442A (en) 1996-05-14
FI952859A0 (en) 1995-06-09
WO1994013304A2 (en) 1994-06-23
KR950703982A (en) 1995-11-17
NO952261L (en) 1995-06-08
CA2150383A1 (en) 1994-06-23
EP0673253A1 (en) 1995-09-27
AU6390894A (en) 1994-07-04
CZ148695A3 (en) 1995-12-13
SK76595A3 (en) 1997-01-08
FI952859A (en) 1995-06-09
WO1994013304A3 (en) 1994-09-01

Similar Documents

Publication Publication Date Title
TR25002A (en) PREPARATION METHOD OF CRITICAL NATRINE
DK42093D0 (en) METHOD OF ADMINISTRATION
NO944164D0 (en) Process for the preparation and use of an HCl adsorbent
IL98618A0 (en) Improved ointment base and method of use
NO934878D0 (en) Cure-activated cement mixtures and methods
DK10289A (en) METHODS AND PREPARATIONS FOR THE PREVENTION OF ULCUS
MX9200273A (en) NEW COMPOUNDS OF SULFONILUREAS AND PROCEDURE FOR ITS OBTAINING
NO972477D0 (en) Meso-mono-iodine substituted tetramacrocyclic compounds and methods of preparation and use
DK0635004T3 (en) 4-Diphenylmethylpiperidine derivatives and process for their preparation
NO932282L (en) Oily preparation and method of preparation thereof
NO940027L (en) Procedure for Preparation of B-Phenylisorerin Derivatives and the Use of Derivatives
NO304890B1 (en) Pharmaceutical compounds and pharmaceutical preparations
NO932860D0 (en) PROCEDURE FOR PREPARATION OF CALCIUM-L-ASCORBATE-2-PHOSPHATE
DK0512547T3 (en) Pain-controlling preparation and method of preparation thereof
NO952261D0 (en) Antacidium Compounds and Methods of Preparation thereof
BR9306359A (en) Azoresants application of azoresis and crystalline modification
NO940634L (en) Anti-ulcer agent and method of preparation thereof
NO934293D0 (en) Methods and Streptomyces Strain for the Preparation of Antiparastic Compounds
NO932375D0 (en) AMIDER DERIVED FROM 3-AMINOETHYL AND PROCEDURE FOR PREPARATION
DK0390762T3 (en) New Bronchospasmolytic Compounds and Methods for their Preparation
DK0425029T3 (en) Crystalline aluminophosphates and related compounds
NO942531D0 (en) Process for the preparation of 3-acyl ostratrienes and acylbenzenes
DK97388A (en) INTERMEDIATE AND PROCEDURE FOR THE PREPARATION OF ANTIHYPERCHOLESTROLEMIC TETRAZOLE COMPOUNDS
FI923360A (en) PROCEDURE FOR FRAMSTATION OF DIMETHYLACETOACETAMIDE
KR950700319A (en) Process of preparing 3-carbonylandrostadiene 17-carboxamides